Chromatin modification by lipids and lipoprotein components: An initiating event in atherogenesis?

Current Opinion in Lipidology

Volumn 16, Issue 5, 2005, Pages 549-553

  Zaina, Silvio ^a   Døssing, Kristina B V ^b   Lindholm, Marie Wickström ^c   Lund, Gertrud ^d  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b University of Copenhagen   (Denmark)

^c LUND UNIVERSITY   (Sweden)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Atherosclerosis; Cancer; Chromatin; DNA methylation; DNA lipid interaction; Epigenetics; Histone; Lipid; Lipoprotein; Nuclear lipid localization

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; BUTYRIC ACID; CHOLESTEROL; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE DEACETYLASE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PROPIONIC ACID; SHORT CHAIN FATTY ACID; STEARIC ACID DERIVATIVE; VALERIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ACETYLATION; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DNA METHYLATION; DNA SEQUENCE; DRUG INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW;

EID: 25444490681     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000180165.70077.ee     Document Type: Review

References (35)

1. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294:1866-1870.
2. Stulnig TM. Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol 2003; 132:310-321.
3. Rawson RB. The SREBP pathway - insights from INSIGs and insects. Nat Rev Mol Cell Biol 2003; 4:631-640.
4. Lipskaia L, Pourci M-L, Deloménie C, et al. Phosphoinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation. Circ Res 2003; 92:1115-1122.
5. Shen GX. Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells. Mol Cell Biochem 2003; 246:69-74.
6. Zeng L, Liao H, Liu Y, et al. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J Biol Chem 2004; 279:48801-48807.
7. Cao S, Fernandez-Zapico ME, Jin D, et al. KLF11-mediated repression antagonizes Sp1/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. J Biol Chem 2005; 280:1901-1910.
8. Hashimshony T, Zhang J, Keshet I, et al. The role of DNA methylation in setting up chromatin structure during development. Nat Genet 2003; 34:187-192.
9. Schubeler D, MacAlpine DM, Scalzo D, et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 2004; 18:1263-1271.
10. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3:662-673.
11. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002; 196:1-7.
12. Tycko B. Genetic and epigenetic mosaicism in cancer precursor tissues. Ann NY Acad Sci 2003; 983:43-54.
13. Laird PW. The power and the promises of DNA methylation markers. Nat Rev Cancer 2003; 3:253-266.
14. Yao X, Hu JF, Daniels M, et al. A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest 2003; 111:265-273.
15. Chen JS, Faller DV, Spanjaard RA. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets 2003; 3:219-236.
16. Dong C, Yoon W, Goldschmidt-Clermont PJ. DNA methylation and atherosclerosis. J Nutr 2002; 132:24065-24095.
17. Hiltunen MO, Ylä-Herttuala S. DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol 2003; 23:1750-1753.
18. Zaina S, Wickström Lindholm M, Lund G. Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? J Nutr 2005; 135:5-8.
19. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003; 133:24855-24933.
20. Benjamin D, Jost JP. Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. Nucl Acids Res 2001; 29:3603-3610.
21. Albi E, Magni MV. The presence of chromatin cholesterol in rat liver regeneration. J Hepatol 2002; 36:395-400.
22. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung disease. J Biochem Mol Biol 2003; 36:95-109.
23. Martelli AM, Manzoli L, Cocco L Nuclear inositides: facts and perspectives. Pharmacol Therapeut 2004; 101:47-64. A review exhaustively covering the current knowledge of the nuclear functions of phosphoinositides.
24. Jones DR, Divecha N. Linking lipids to chromatin. Curr Opin Genet Dev 2004; 14:196-202. Another important review on lipids and chromatin, focusing exclusively on phosphoinositides. Importantly, the authors forward the hypothesis that nuclear phosphoinositide-binding proteins are novel chromatin remodelling factors, thus providing interesting leads for future experimental work.
25. Kuvichkin VV. DNA-lipid interactions in vitro and in vivo. Bioelectrochemistry 2002; 58:3-12.
26. DePaoli-Roach A, Roach PJ, Zucker KE, Smith SS. Selective phosphorylation of human DNA methyltransferase by protein kinase C. FEBS Lett 1986; 197:149-153.
27. Albi E, Viola Magni MP. The role of intranuclear lipids. Biol Cell 2004; 96:657-667. Comprehensive, touching broad aspects of lipid nuclear functions including the regulation of DNA and RNA stability.
28. Panin LE, Polyakov LM, Kolosova NG, et al. Distribution of tocopherol and apolipoprotein A-I immunoreactivity in rat liver chromatin. Membr Cell Biol 1998; 11:631-640.
29. Panin LE, Tuzikov FV, Gimautdinova OI. Tetrahydrocortisol-apolipoprotein A-I complex specifically interacts with eukaryotic DNA and GCC elements of genes. J Ster Biochem Mol Biol 2003; 87:309-318.
30. Bird A, Tate P, Nan X, et al. Studies of DNA methylation in animals. J Cell Sci Suppl 1995; 19:37-39.
31. Panin LE, Russkikh GS, Polyakov LM. Detection of apolipoprotein A-I, B, and E immunoreactivity in the nuclei of various rat tissue cells. Biochemistry (Moscow) 2000; 65:1419-1423.
32. Guevara JG Jr, Kang D, Moore JP. Nucleic acid-binding properties of low-density lipoproteins: LDL as a natural gene vector. J Protein Chem 1999; 18:845-857.
33. WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells. Int J Cancer 2004; 109:207-213. A study describing the butyrate-independent modifications of chromatin-associated factors that are necessary for butyrate-induced gene transcription.
34. Calonghi N, Cappadone C, Pagnotta E, et al. Histone deacetylase 1: a target of 9-hydroxystearic acid in the inhibition of cell growth in human colon cancer. J Lipid Res 16 February 2005 (E-published ahead of printing). An important work showing that one endogenous lipid peroxidation product inhibits histone deacetylase activity by direct binding to the catalytic site of the enzyme.
35. Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004; 279:29147-29154. A genome-wide analysis of sequences undergoing DNA methylation changes in atherosclerosis in a mouse model. In addition, the study shows that atherogenic lipoprotein profiles alter DNA methylation patterns in cultured cells.